Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in FBIO — Fortress Biotech, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to FBIO Full portfolio

Position in FBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,300
-$14,204 QoQ
Shares Held
5,000
-52.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 55 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. FBIO ranks #314 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in FBIO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,300 5,000
2026-03-31 $29,504 10,575
2025-12-31 $18,300 5,000
2025-09-30 $18,500 5,000
2025-03-31 $24 16
2024-12-31 $18,282 9,006
2024-09-30 $12,548 8,654
2024-06-30 $14,420 8,433
2024-03-31 $34,988 17,494
2023-12-31 $1,197 398
2023-09-30 $45,600 157,245
2023-06-30 $43,404 78,919
2023-03-31 $51,848 63,231
2022-12-31 $31,310 47,441
2022-09-30 $27,333 31,784
2022-06-30 $13,587 16,177
2022-03-31 $304,681 224,031
2021-12-31 $569,095 227,638
2021-09-30 $186,270 57,848
2021-06-30 $542,539 151,972
2021-03-31 $257,417 72,923
2020-12-31 $482,663 152,260
2020-09-30 $540,386 133,759
2020-06-30 $257,807 96,197
2020-03-31 $527 279